DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Vultaggio A. et al.
Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions.
Clin Exp Immunol 2016;
186: 364-372
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.